Home Neoplasma Ahead of print neo_2019_190415N334

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

neo_2019_190415N334

Title: The potential of ciRS-7 for predicting onset and prognosis of cervical cancer
Author: Y. Zhou, L. Shen, Y. Z. Wang, C. C. Zhou

Abstract: Considering the potency of circRNAs in manifesting neoplastic progression, we attempted to explore the feasibility of applying ciRS-7 for diagnosis and prognosis estimation of cervical cancer (CC). Here 352 CC patients, 204 cervical intraepithelial neoplasia (CIN) patients and 227 healthy controls were recruited. The Kaplan-Meier survival curves were fitted to estimate associations of ciRS-7 expression with CC prognosis, and we also adopted receiver operating characteristic (ROC) curves to assess the diagnostic performance of ciRS-7 for CC. Meanwhile, endometrial stromal cell line (ESC) and 4 human CC cell lines (i.e. Hela, Caski, C33A and SiHa) were also gathered. After transfection of pcDNA3.1-ciRS-7, impacts of over-expressed ciRS-7 on proliferation, apoptosis, invasion and migration of CC cells were assessed through performing colony formation assay, flow cytometry, transwell assay and wound healing assay. The results demonstrated that CC patients that highly expressed ciRS-7 were associated with high odds of large tumor size, advanced FIGO stage, deep invasion, metastatic lymph nodes and HPV infection (P

Keywords: ciRS-7, cervical cancer, CEA, CA-125, combined diagnosis, ROC curve, cell proliferation, epithelial-mesenchymal transition
Published online: 27-Dec-2019
Year: , Volume: , Issue: Page From: , Page To:
doi:10.4149/neo_2019_190415N334


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.